The microbiome is the ecosystem of micro-organisms that live in and around us, mostly in our gut. It plays a major role in human health, and when out of balance causes diseases such as chronic digestive disorders, diabetes, obesity, allergies, auto-immune diseases and much else.
We have a genotype and a phenotype. What everyone also has is a "microtype:" The composition of the microbiome. It affects the response to treatments as well as our food and lifestyle.
REM Analytics provides a novel method to profile the microtype in people.
For companies producing probiotics, prebiotics, functional foods or other microbiome affecting products, we provide the evidence needed to demonstrate the efficacy of your products.
We have the unique capability to measure the colonization of specific probiotic strain in the microbiome of people. Also, we can measure the effect of these strains on the microtype at large, as well as differences induced by changes in food and lifestyle. Accurate profiling of the microtype has the potential to identify sub-populations that are more likely to be treated by a probiotic.
In the long run, our objecitve is to allow the development of Evidence-based, personalised microbiome based treatments.
Company Details
- Employees
- 5
- Founded
- -
- Address
- Epfl, Station 8,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- remanalytics.ch
- HQ
- Lausanne, Vaud
Rem Analytics Questions
Rem Analytics's website is remanalytics.ch
Rem Analytics's LinkedIn profile is https://ch.linkedin.com/company/rem-analytics
Rem Analytics has
5 employees.
View email and phone details for 5
employees at Rem Analytics.
Rem Analytics's industry is
Biotechnology Research
Rem Analytics's top competitors are
Immunskills Sa,
Orio Therapeutics,
Fluosphera,
Bioark,
Ymmunobio,
Alphaonco Swiss Sa,
Yoni Solutions,
Ceidos,
3d2cut Sa,
Novochizol Sa.
Rem Analytics's categories are Biotechnology Research
Rem Analytics's founding year is 2019
